Related Experiment Video

Updated: Sep 15, 2025

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

8.5K

Decoding TAGLN2 in cancer: the molecular linchpin bridging actin remodeling, immune dysregulation and therapeutic

Xie-Lin Yan1, Jun-Jie Wu2, Hui-Bo Ti1

  • 1Wuxi Medical College, Jiangnan University, Wuxi, China; Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Jiangsu, China.

International Journal of Biological Macromolecules
|July 17, 2025
PubMed

Insights

Transgelin 2 (TAGLN2) is vital for cancer progression, influencing invasion and immune evasion. Understanding its specific roles and targeting it may offer new precision therapies for diverse cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cancer progression relies on tumor-microenvironment interactions, with actin cytoskeleton dynamics critical for invasion, metastasis, and immune evasion.
  • Transgelin 2 (TAGLN2) is a key cytoskeletal regulator impacting tumor progression via actin dynamics, signaling, and epigenetics.
  • TAGLN2 shows promise as a pan-cancer biomarker and therapeutic target, but its tissue-specific expression and mechanisms require further clarification.

Purpose of the Study:

  • To elucidate TAGLN2's molecular and biochemical characteristics.
  • To systematically summarize TAGLN2 expression profiles across various tumors and evaluate associated signaling pathways.
  • To examine TAGLN2's mechanisms in tumorigenesis and progression, and discuss therapeutic strategies.

Main Methods:

  • Literature review and analysis of existing data on TAGLN2.
  • Systematic evaluation of TAGLN2 expression patterns in different cancer types.
  • Analysis of signaling pathways and epigenetic modifications linked to TAGLN2.
  • Review of current and potential therapeutic strategies targeting TAGLN2.

Main Results:

  • TAGLN2 integrates actin dynamics, signaling, and epigenetic modifications to influence tumor progression.
  • TAGLN2 exhibits diverse expression patterns across clinical tumors, impacting invasion, metastasis, and immune evasion.
  • Specific molecular mechanisms and signaling pathways modulated by TAGLN2 in tumorigenesis are identified.

Conclusions:

  • TAGLN2 is a significant factor in cancer development, influencing key processes like invasion and immune evasion.
  • Further research into TAGLN2's role in the tumor microenvironment is crucial for developing effective therapies.
  • Targeting TAGLN2, particularly in conjunction with cytoskeletal remodeling and immune metabolic regulation, holds promise for overcoming tumor heterogeneity and therapeutic resistance.
Keywords:
Actin cytoskeletonImmune metabolism regulationTherapeutic resistanceTransgelin 2 (TAGLN2)Tumor microenvironment (TME)

More Related Videos

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

6.1K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.1K

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.1K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K